LEO 27847

· LEO Pharma

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LEO 27847, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients [Phase 1]

See pricing